Lisa Revie

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Journal: Neurology
Published: July 02, 2026

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.

Journal: EBioMedicine
Published: May 30, 2025

B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab.

B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab.

Journal: iScience
Published: April 04, 2025

Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab.

Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 03, 2025

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).

Journal: Frontiers in immunology
Published: February 12, 2025

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Journal: Neurology
Published: October 01, 2024

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 02, 2024

Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.

Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.

Journal: Journal of neurology
Published: July 08, 2024
Showing 1-8 of 8

Last Updated: 09/26/2026